西亚试剂优势供应上万种化学试剂产品，欢迎各位新老客户咨询、选购！
中国
联系我们

登录

￥0.00

联系方式：400-990-3999 / 邮箱：sales@xiyashiji.com

西亚试剂 —— 品质可靠，值得信赖

西亚试剂：Interferon modulation of cellular microRNAs as an antiviral

Interferon modulation of cellular microRNAs as an antiviral mechanism

Irene M. Pedersen1, Guofeng Cheng3, Stefan Wieland3, Stefano Volinia4, Carlo M. Croce4, Francis V. Chisari3 & Michael David1,2

  1. Department of Molecular Biology,
  2. Division of Biological Sciences, and,
  3. Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA
  4. Division of Experimental Pathology, The Scripps Research Institute, La Jolla, California 92037, USA
  5. Department of Molecular Virology, Immunology & Medical Genetics, Ohio State University, Columbus, Ohio 43210, USA

Correspondence to: Michael David1,2 Correspondence and requests for materials should be addressed to M.D. (Email: midavid@ucsd.edu).

RNA interference through non-coding microRNAs (s) represents a vital component of the innate antiviral immune response in plants and invertebrate animals; however, a role for cellular miRNAs in the defence against viral infection in mammalian organisms has thus far remained elusive1. Here we show that interferon beta (IFNbeta) rapidly modulates the expression of numerous cellular miRNAs, and that eight of these IFNbeta-induced miRNAs have sequence-predicted targets within the hepatitis C virus (HCV) genomic RNA. The introduction of synthetic miRNA-mimics corresponding to these IFNbeta-induced miRNAs reproduces the antiviral effects of IFNbeta on HCV replication and infection, whereas neutralization of these antiviral miRNAs with anti-miRNAs reduces the antiviral effects of IFNbeta against HCV. In addition, we demonstrate that IFNbeta treatment leads to a significant reduction in the expression of the liver-specific miR-122, an miRNA that has been previously shown to be essential for HCV replication2. Therefore, our findings strongly support the notion that mammalian organisms too, through the interferon system, use cellular miRNAs to combat viral infections.